GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.17G039300	P01049	Modafinil	1	6.54482009276083e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P02143	keto-1,4-benzoquinone	1	9.55751326027682e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P02600		1	8.14506772162199e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P02768	Falconensin C	1	9.45581708667799e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P04515	Impromidine	1	3.97207084113688e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P07865	4-Hydroxylaminobenzoate	1	7.27070985766242e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P08696	Cyclohexylamine	1	9.74610507408625e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P09651		1	3.95094102297671e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P10133	Teucrolin D	1	2.91843118118533e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P13824	(2S)-2-Amino-3-[4-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]oxyphenyl]propanoic acid	1	3.26133897332865e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P15701		1	1.42603873690691e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P16826	L-Noradrenaline	1	1.27734817702971e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P19549	Difloxacin	1	2.60909204491862e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P24826	Actinoplanone G	1	1.65169759035767e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P25528	Shizukaol L	1	5.91446838419645e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P25608	Glycoperine	1	5.54486476318639e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P27511		1	9.96519377905536e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P28410	HC-toxin	1	1.93556487897222e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P28434	5,6-Epoxyoctadeca-7,9-diynoic acid	1	4.01232671400089e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P29567	Lesopitron	1	8.9264333232969e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P30563	Yadanzioside E	1	4.35791630994495e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P31878	Stryspinolactone	1	1.08082867000312e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P32030		1	1.38330207873853e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P33829		1	8.30753676899004e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P40400	Chellespontine	1	5.0128521746559e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P41025	CDP-DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15))	1	1.98475675451174e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P41059	3R-hydroxy-14-((1H-indol-3-ylcarbonyl)3,6-dideoxy-alpha-L-arabino-hexopyranosyloxy)-tetradecanoic acid	1	2.85355765531894e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P44718	Candicanoside A	1	4.73485680715667e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P46023	Rapisterone	1	1.27751586758668e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P46563	24-dimethoxy-3beta,6beta,19alpha-trihydroxyurs-12-en-28-oic acid	1	9.3937007908659e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P48347	2,4-Decadienamide,5-(4-methoxyphenyl)-N-[(1R)-1-methyl-4-(3-pyridinyl)butyl]-, (2E,4E)-	1	3.47457085835233e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P49790		1	2.17171873925598e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P50846	4-Methylburimamide	1	3.82091304192338e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P51637	Pentenylbenzene	1	5.78778782642536e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P51669		1	8.58334941308616e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P52808		1	5.25196070242064e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P54042	Daphniphylline	1	6.61551008258568e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P54628		1	2.70078832714594e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G039300	P55075	Norhygrine	1	6.09594496275379e-11	overlap	1e-10	<	Wm82.a2.v1